|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61P 9/00 | (2006.01) |
| A61K 31/397 | (2006.01) | ||
| A61K 31/215 | (2006.01) |
| (11) | Number of the document | 1413331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04000161.2 |
| Date of filing the European patent application | 2002-01-25 | |
| (97) | Date of publication of the European application | 2004-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-03 |
| (46) | Date of publication of the claims translation | 2007-12-27 |
| (30) | Number | Date | Country code |
| 264396 P | 2001-01-26 | US | |
| 323839 P | 2001-09-21 | US |
| (72) |
Kosoglou, Teddy, US
Davis, Harry R., US
Picard, Gilles Jean Bernard, BE
|
| (73) |
Organon LLC,
30 Hudson Street, Jersey City, New Jersey 07302-4699,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Peroksisomų poliferatoriaus aktyvuoto receptoriaus (PPAR) aktyvatoriaus fenofibrato deriniai su sterolio absorbcijos inhibitoriumi ezetimibu, skirti kraujagyslių indikacijoms |
| Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| Payment date | Validity (years) | Amount | |
| 2021-01-12 | 347.00 EUR |